Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Healthcare-sector
0
SHARES
14
VIEWS
Share on FacebookShare on Twitter

Recent data from March 15, 2024, reveals that Molina Healthcare Inc. (MOH) has seen a surge in short interest, with 1.66 million shares being sold short. This represents 3.25% of all regular shares available for trading. The uptick in short interest suggests a growing bearish sentiment towards the stock.

Short interest is a key indicator of market sentiment, with an increase indicating heightened bearishness and a decrease potentially signaling increased bullishness. Short selling involves traders selling shares they do not own in anticipation of a price drop to profit from the variance. Monitoring short interest is crucial as it can offer valuable insights into market expectations for a specific stock.

In the case of Molina Healthcare, the recent spike in short interest points towards a more pessimistic outlook among investors. However, it’s essential to remember that while rising short interest can serve as a red flag, it does not guarantee an immediate decline in stock price. Traders should exercise caution and consider this information in conjunction with other factors when making investment decisions.

Molina Healthcare, Inc. (MOH) Closes Slightly Lower on March 15, 2024 – After-Hours Trading Indicates Potential for Price Movement

On March 15, 2024, Molina Healthcare, Inc. (MOH) closed at $404.45, a decrease of $2.23 or 0.55% from the previous market close. MOH is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum.

After the market closed, MOH saw a slight uptick in after-hours trading, rising by $0.00. Any movement in after-hours trading can provide insights into investor sentiment and potential price movements for the following trading day.

Stock prices can be influenced by company performance, market conditions, and macroeconomic trends. Investors should conduct thorough research and analysis before making any investment decisions based on stock performance alone.

MOH’s performance on March 15, 2024, suggests that the stock is holding steady despite the slight drop in price. Investors will be watching MOH closely in the coming days to see if it can maintain its upward momentum and potentially reach new highs.

Molina Healthcare Inc. (MOH) Reports Strong Financial Performance in 2023 but Sees Stock Fluctuations in Q4 2024

On March 15, 2024, Molina Healthcare Inc. (MOH) saw a mixed performance in its stock based on the latest financial data released by the company. According to CNN Money, the total revenue for the company stood at $34.07 billion for the past year, with a significant increase of 6.56% compared to the previous year.

The net income for Molina Healthcare Inc. was $1.09 billion for the past year, marking a substantial 37.75% increase from the previous year. However, in the fourth quarter, the net income decreased by 11.84% to $216.00 million. This fluctuation in net income could have influenced the stock performance on March 15, 2024.

Earnings per share (EPS) for Molina Healthcare Inc. were reported at $18.78 for the past year, showing a 38.7% increase from the previous year. In the fourth quarter, the EPS remained flat at $3.71. Despite the consistent EPS in the last quarter, the overall increase in EPS for the year could have positively impacted the stock performance.

Overall, the financial indicators for Molina Healthcare Inc. show a strong performance over the past year, with significant increases in total revenue, net income, and earnings per share. However, the slight decrease in net income in the fourth quarter could have affected the stock performance on March 15, 2024. Investors and analysts will closely monitor the company’s future financial results to assess the trajectory of MOH stock in the coming months.

Tags: MOH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Biotechnology Stock Bull Market
Breaking News

Analyzing Short Interest in Rigetti Computing and Its Peers

March 15, 2024
Next Post
Businesses finance

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

NFT projects

The Impact of TikToks Fate on USChina Relations and American Tech Giants

Real Estate

The Future of Work: How Remote Work Trends are Reshaping Japan's Real Estate Landscape

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com